Insight Molecular Diagnostics Inc. (IMDX)
(Delayed Data from NSDQ)
$2.77 USD
+0.21 (8.20%)
Updated Aug 4, 2025 03:59 PM ET
After-Market: $2.77 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Insight Molecular Diagnostics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical Info Systems industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IMDX 2.77 +0.21(8.20%)
Will IMDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMDX
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
IMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IMDX
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual ...
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft ...
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant ...
12 Health Care Stocks Moving In Friday's After-Market Session
Insight Molecular Diagnostics (IMDX) Gets a Buy from Lake Street